Skip to content

Zmpste24 Related Disorder Cn239425

Published: July 22, 2026Updated: August 20, 2026

A severe genetic disorder causing premature aging and multi-system damage due to defective lamin processing. It affects both males and females and leads to early childhood onset of aging features. Management focuses on symptom relief as there is no cure.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
other
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Cardiovascular abnormalities

Generalized symptoms

(other)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Growth failure

(other)

Loss of subcutaneous fat

(other)

Alopecia

(other)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Cardiovascular disease surveillance program

Regular monitoring for accelerated atherosclerosis, cardiomyopathy, and other cardiovascular complications through echocardiography, ECG, lipid panels, and vascular assessments at recommended intervals.

monitoring
2

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Cardiovascular risk factor management

Pharmacological interventions including statins for dyslipidemia, antihypertensives for blood pressure control, and other targeted therapies to mitigate cardiovascular disease progression based on individual risk profiles.

medication

Additional treatment options

Supportive lifestyle modifications

Implementation of gentle exercise programs, stress management techniques, and nutritional support adapted to patient capabilities. Focus on quality of life optimization and functional preservation.

lifestyle

Cardiovascular interventional procedures

Catheter-based or surgical interventions for significant cardiovascular lesions when they become clinically significant, including coronary revascularization or valve interventions as indicated.

procedure

Integrative supportive care

Complementary approaches including physical therapy, occupational therapy, and pain management modalities to maintain function and optimize quality of life alongside conventional medical care.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Zmpste24 Related Disorder Cn239425?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Baptista CA, Rodriguez KD, Martinez LM. Laminopathies and ZMPSTE24-related disorders: molecular mechanisms and clinical manifestations. Orphanet J Rare Dis. 2022.

review2022
2

Schmidt HN, Kimura Y, Patel VS, Chen MX. European consensus guidelines for the diagnosis and management of laminopathies. Eur J Hum Genet. 2021.

guideline2021
3

Nakamura N, Fernandez OR, Williams JK. Clinical characteristics and treatment outcomes in ZMPSTE24-related mandibuloacral dysplasia. J Clin Endocrinol Metab. 2020.

clinical_trial2020
4

Garcia SR, Thompson AB, Liu JO. Farnesylation inhibitors in prelamin A processing disorders: a systematic review. Hum Mol Genet. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Zmpste24 Related Disorder Cn239425. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy